BACKGROUND: Soluble transferrin receptor (sTfR) assays are currently not standardized. This hinders data comparison between studies and also affects the use of a recently proposed model to estimate body iron. METHODS: We evaluated the analytical performance of a fully automated sTfR immunoturbidimetric assay (Roche Diagnostics) and compared it with two ELISA assays (Ramco Laboratories and an in-house ELISA assay used in the body iron model). RESULTS: The Roche assay showed excellent intra- and inter-assay precision (CV<5%). Prolonged exposure of serum samples to room temperature and multiple freeze-thaw cycles did not affect sTfR concentrations. Receiver-operator characteristic curve analysis demonstrated that the Roche assay (area-under-the-curve (AUC)=0.882) was superior to the Ramco assay (AUC=0.794) in predicting iron deficiency (defined as serum ferritin <10 microg/L; P=0.013). Method comparison between the Roche and the two ELISA assays showed good correlations (r>0.8); however, sTfR values by the Roche assay were on average 30% lower than values obtained with the two ELISA assays. CONCLUSIONS: sTfR data measured with an immunoturbidimetric assay can be compared to a commonly used ELISA assay, and can be used in the body iron model through regression equations obtained in the present study.
BACKGROUND: Soluble transferrin receptor (sTfR) assays are currently not standardized. This hinders data comparison between studies and also affects the use of a recently proposed model to estimate body iron. METHODS: We evaluated the analytical performance of a fully automated sTfR immunoturbidimetric assay (Roche Diagnostics) and compared it with two ELISA assays (Ramco Laboratories and an in-house ELISA assay used in the body iron model). RESULTS: The Roche assay showed excellent intra- and inter-assay precision (CV<5%). Prolonged exposure of serum samples to room temperature and multiple freeze-thaw cycles did not affect sTfR concentrations. Receiver-operator characteristic curve analysis demonstrated that the Roche assay (area-under-the-curve (AUC)=0.882) was superior to the Ramco assay (AUC=0.794) in predicting iron deficiency (defined as serum ferritin <10 microg/L; P=0.013). Method comparison between the Roche and the two ELISA assays showed good correlations (r>0.8); however, sTfR values by the Roche assay were on average 30% lower than values obtained with the two ELISA assays. CONCLUSIONS: sTfR data measured with an immunoturbidimetric assay can be compared to a commonly used ELISA assay, and can be used in the body iron model through regression equations obtained in the present study.
Authors: Sindhu Lakkur; Roberd M Bostick; Douglas Roblin; Murugi Ndirangu; Ike Okosun; Francis Annor; Suzanne Judd; W Dana Flanders; Victoria L Stevens; Michael Goodman Journal: Biomarkers Date: 2014-07-02 Impact factor: 2.658
Authors: Walter Bialkowski; Joseph E Kiss; David J Wright; Ritchard Cable; Rebecca Birch; Pam D'Andrea; Barbara J Bryant; Bryan R Spencer; Alan E Mast Journal: Am J Hematol Date: 2017-06-09 Impact factor: 10.047
Authors: A Z Khambalia; C E Collins; C L Roberts; J M Morris; K L Powell; V Tasevski; N Nassar Journal: Eur J Clin Nutr Date: 2015-09-16 Impact factor: 4.016
Authors: Ritchard G Cable; Donald Brambilla; Simone A Glynn; Steven Kleinman; Alan E Mast; Bryan R Spencer; Mars Stone; Joseph E Kiss Journal: Transfusion Date: 2016-05-27 Impact factor: 3.157
Authors: Sean Lynch; Christine M Pfeiffer; Michael K Georgieff; Gary Brittenham; Susan Fairweather-Tait; Richard F Hurrell; Harry J McArdle; Daniel J Raiten Journal: J Nutr Date: 2018-06-01 Impact factor: 4.798